BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1105 related articles for article (PubMed ID: 24802860)

  • 1. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
    Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
    Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment.
    Sikjaer T; Amstrup AK; Rolighed L; Kjaer SG; Mosekilde L; Rejnmark L
    J Bone Miner Res; 2013 Oct; 28(10):2232-43. PubMed ID: 23649554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study.
    Clarke BL; Vokes TJ; Bilezikian JP; Shoback DM; Lagast H; Mannstadt M
    Endocrine; 2017 Jan; 55(1):273-282. PubMed ID: 27734257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of vitamin D unresponsive hypoparathyroidism with multipulse subcutaneous infusion of teriparatide.
    Puig-Domingo M; Díaz G; Nicolau J; Fernández C; Rueda S; Halperin I
    Eur J Endocrinol; 2008 Nov; 159(5):653-7. PubMed ID: 18703565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study.
    Mannstadt M; Clarke BL; Vokes T; Brandi ML; Ranganath L; Fraser WD; Lakatos P; Bajnok L; Garceau R; Mosekilde L; Lagast H; Shoback D; Bilezikian JP
    Lancet Diabetes Endocrinol; 2013 Dec; 1(4):275-83. PubMed ID: 24622413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose subcutaneous administration of recombinant human parathyroid hormone [rhPTH(1-84)] in healthy postmenopausal volunteers.
    Schwietert HR; Groen EW; Sollie FA; Jonkman JH
    Clin Pharmacol Ther; 1997 Mar; 61(3):360-76. PubMed ID: 9084461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism.
    Mannstadt M; Clarke BL; Bilezikian JP; Bone H; Denham D; Levine MA; Peacock M; Rothman J; Shoback DM; Warren ML; Watts NB; Lee HM; Sherry N; Vokes TJ
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5136-5147. PubMed ID: 31369089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug safety evaluation of parathyroid hormone for hypocalcemia in patients with hypoparathyroidism.
    Marcucci G; Della Pepa G; Brandi ML
    Expert Opin Drug Saf; 2017 May; 16(5):617-625. PubMed ID: 28332412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AN OPEN-LABEL EXTENSION STUDY OF PARATHYROID HORMONE RHPTH(1-84) IN ADULTS WITH HYPOPARATHYROIDISM.
    Lakatos P; Bajnok L; Lagast H; Valkusz Z
    Endocr Pract; 2016 May; 22(5):523-32. PubMed ID: 26684150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human parathyroid hormone (1-84) replacement therapy in a child with hypoparathyroidism.
    Laurer E; Grünberger J; Naidoo U; Lanzersdorfer R; Wimleitner M; Tischlinger K; Högler W
    Bone; 2021 Mar; 144():115834. PubMed ID: 33359892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects on calcium homeostasis of changing PTH replacement therapy of postoperative hypoparathyroidism from intact PTH to teriparatide: a case series.
    Bislev LS; Sikjaer T; Rejnmark L
    Calcif Tissue Int; 2014 Oct; 95(4):374-81. PubMed ID: 25086672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of hypoparathyroidism with intact parathyroid hormone.
    Rubin MR; Sliney J; McMahon DJ; Silverberg SJ; Bilezikian JP
    Osteoporos Int; 2010 Nov; 21(11):1927-34. PubMed ID: 20094706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism.
    Khan AA; Rejnmark L; Rubin M; Schwarz P; Vokes T; Clarke B; Ahmed I; Hofbauer L; Marcocci C; Pagotto U; Palermo A; Eriksen E; Brod M; Markova D; Smith A; Pihl S; Mourya S; Karpf DB; Shu AD
    J Clin Endocrinol Metab; 2022 Jan; 107(1):e372-e385. PubMed ID: 34347093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism.
    Winer KK; Zhang B; Shrader JA; Peterson D; Smith M; Albert PS; Cutler GB
    J Clin Endocrinol Metab; 2012 Feb; 97(2):391-9. PubMed ID: 22090268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of Hypoparathyroidism With PTH(1-84): A Prospective Six Year Investigation of Efficacy and Safety.
    Rubin MR; Cusano NE; Fan WW; Delgado Y; Zhang C; Costa AG; Cremers S; Dworakowski E; Bilezikian JP
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2742-50. PubMed ID: 27144931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTH(1-34) for Surgical Hypoparathyroidism: A Prospective, Open-Label Investigation of Efficacy and Quality of Life.
    Santonati A; Palermo A; Maddaloni E; Bosco D; Spada A; Grimaldi F; Raggiunti B; Volpe R; Manfrini S; Vescini F;
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3590-7. PubMed ID: 26196949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of Hypoparathyroidism With rhPTH(1-84): A Prospective, 8-Year Investigation of Efficacy and Safety.
    Tay YD; Tabacco G; Cusano NE; Williams J; Omeragic B; Majeed R; Gomez Almonte M; Bilezikian JP; Rubin MR
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5601-5610. PubMed ID: 31310310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid Hormone Replacement Therapy in Hypoparathyroidism: A Meta-Analysis.
    Liu XX; Zhu XY; Mei GH
    Horm Metab Res; 2016 Jun; 48(6):377-83. PubMed ID: 27254756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous rhPTH (1-34) treatment in chronic hypoparathyroidism.
    Fuss CT; Burger-Stritt S; Horn S; Koschker AC; Frey K; Meyer A; Hahner S
    Endocrinol Diabetes Metab Case Rep; 2020 May; 2020():. PubMed ID: 32478671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Parathyroid Hormone 1-34 Replacement Therapy in Children with Hypoparathyroidism.
    Winer KK; Kelly A; Johns A; Zhang B; Dowdy K; Kim L; Reynolds JC; Albert PS; Cutler GB
    J Pediatr; 2018 Dec; 203():391-399.e1. PubMed ID: 30470382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.